• Changes in the S&P/ASX Indices effective prior to the open of trading on March 24, 2025
• Additions and removals across the S&P/ASX 20, 50, 100, 200, and 300 indices
• All Ordinaries index also sees changes in constituents

S&P Dow Jones Indices announced the changes in the S&P/ASX Indices, effective prior to the open of trading on Monday, March 24, 2025, as a result of the March quarterly review. There will be no changes to the S&P/ASX 20 Index. In the S&P/ASX 50 Index, Pro Medicus Limited and Sigma Healthcare Limited will be added, while Mineral Resources Limited and Ramsay Health Care Limited will be removed. For the S&P/ASX 100 Index, Life360 Inc. and Sigma Healthcare Limited will be added, and Iluka Resources Limited and NIB Holdings Limited will be removed. The S&P/ASX 200 Index will see several changes, with the addition of Capstone Copper Corp., DigiCo Infrastructure REIT, Imdex Limited, Macquarie Technology Group Limited, Nuix Limited, and Spartan Resources Limited, among others. The S&P/ASX 300 Index will also undergo changes, with the addition of several companies, including Botanix Pharmaceuticals Limited, Catapult Group International Limited, and Catalyst Metals Limited. The All Ordinaries index will see a significant number of additions and removals as part of the quarterly rebalance.